HLA class II antigen expression and the autoimmune thyroid response in patients with benign and malignant thyroid tumors
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 48 (2) , 161-173
- https://doi.org/10.1016/0090-1229(88)90080-3
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- HLA‐DP, DQ and DR gene expression in Graves' disease and normal thyroid epitheliumTissue Antigens, 1987
- AUTOIMMUNE THYROIDDISEASE AND THYROID CELL CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENSClinical Endocrinology, 1987
- "ABERRANT" MHC CLASS II EXPRESSION IN EPITHELIAThe Lancet, 1987
- Expression of HLA‐D sub‐region products on human colorectal carcinomaInternational Journal of Cancer, 1986
- Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid originHuman Immunology, 1986
- Divergent Expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodiesImmunobiology, 1985
- T-Cell Proliferation and Expression of MHC Class II AntigensScandinavian Journal of Immunology, 1984
- A matrix approach to human class II histocompatibility antigens: Reactions of four monoclonal antibodies with the products of nine haplotypesImmunogenetics, 1984
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Cellular Distribution, Purification, and Molecular Nature of Human la AntigensScandinavian Journal of Immunology, 1977